Urgent.News

What's breaking now, across thousands of outlets.

More in Business

Samsung Electronics Invests in Samsung Biologics Rights Offering

Samsung Electronics will participate in a paid-in capital increase by Samsung Biologics, investing 666.2 billion won (about $500 million).Samsung Electronics disclosed on Oct.

  • Samsung Electronics invests 666.2 billion won in Samsung Biologics rights offering.
  • Company acquires 567,503 common shares, signaling significant shareholder role.
  • Deadline for payment is November 17, with Samsung C&T as largest shareholder.

More from Thursday 29 October →